CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | GADICKE ANSBERT Former 10% Owner | Sale 10b5-1 | −83,230 | $0.97 | $81K | 4,784,111 |
| 2025-12-04 | EVNIN LUKE Director | Sale 10b5-1 | −53,416 | $0.97 | $52K | 3,068,278 |
| 2025-12-03 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale 10b5-1 | −57,225 | $0.87 | $50K | 4,867,341 |
| 2025-12-03 | GADICKE ANSBERT Former 10% Owner | Sale 10b5-1 | −57,225 | $0.87 | $50K | 4,867,341 |
| 2025-12-03 | EVNIN LUKE Director | Sale 10b5-1 | −36,726 | $0.87 | $32K | 3,121,694 |
| 2025-12-02 | MPM BioVentures 2014, L.P. Former 10% Owner | Sale 10b5-1 | −59,277 | $0.89 | $53K | 4,924,566 |
| 2025-12-02 | GADICKE ANSBERT Former 10% Owner | Sale 10b5-1 | −59,277 | $0.89 | $53K | 4,924,566 |
| 2025-12-02 | EVNIN LUKE Director | Sale 10b5-1 | −38,043 | $0.89 | $34K | 3,158,420 |
| 2025-12-01 | MPM BioVentures 2014, L.P. 10% owner | Sale 10b5-1 | −60,917 | $0.94 | $57K | 4,983,843 |
| 2025-12-01 | GADICKE ANSBERT 10% owner | Sale 10b5-1 | −60,917 | $0.94 | $57K | 4,983,843 |
| 2025-12-01 | EVNIN LUKE Director | Sale 10b5-1 | −39,096 | $0.94 | $37K | 3,196,463 |
| 2025-11-28 | MPM BioVentures 2014, L.P. 10% owner | Sale 10b5-1 | −20,277 | $0.99 | $20K | 5,044,760 |
| 2025-11-28 | GADICKE ANSBERT 10% owner | Sale 10b5-1 | −20,277 | $0.99 | $20K | 5,044,760 |
| 2025-11-28 | EVNIN LUKE Director | Sale 10b5-1 | −13,014 | $0.99 | $13K | 3,235,559 |
| 2025-11-26 | MPM BioVentures 2014, L.P. 10% owner | Sale 10b5-1 | −60,733 | $0.98 | $60K | 5,065,037 |
| 2025-11-26 | GADICKE ANSBERT 10% owner | Sale 10b5-1 | −60,733 | $0.98 | $60K | 5,065,037 |
| 2025-11-26 | EVNIN LUKE Director | Sale 10b5-1 | −38,978 | $0.98 | $38K | 3,248,573 |
| 2025-11-25 | MPM BioVentures 2014, L.P. 10% owner | Sale 10b5-1 | −42,533 | $0.92 | $39K | 5,125,770 |
| 2025-11-25 | GADICKE ANSBERT 10% owner | Sale 10b5-1 | −42,533 | $0.92 | $39K | 5,125,770 |
| 2025-11-25 | EVNIN LUKE Director | Sale 10b5-1 | −27,297 | $0.92 | $25K | 3,287,551 |
Page 5 of 17 · 335 trades